Sweden· SE-20150122000014
Fibclot 1,5 g Pulver och vätska till injektions-/infusionsvätska, lösning
A medicinal product containing human fibrinogen, registered in Sweden by Laboratoire français du Fractionnement et des Biotechnologies.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Human Fibrinogen
- Manufacturer
- Laboratoire français du Fractionnement et des Biotechnologies
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20150122000014
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Human fibrinogen in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumFibclot 1.5 gLaboratoire français du Fractionnement et des Biotechnologies
- SpainFIBCLOT 1,5 G POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSIONLaboratoire Francais Du Fractionnement Et Des Biotechnologies
- FinlandFibclotLaboratoire Francais du Fractionnement et des Biotechnologies
- United KingdomARTISS solution for sealant 10ml pre-filled syringesBaxter Healthcare Ltd
- IrelandFIBRYGA 2 g powder and solvent for solution for injection/infusionOctapharma (IP)
- GermanyFibclotLaboratoire Francais Du Fractionnement Et Des Biotechnologies
- NetherlandsFibclot 1,5 g, poeder en oplosmiddel voor oplossing voor injectie/infusieLaboratoire Francais Du Fractionnement Et Des Biotechnologies
- CzechiaFIBRYGAOctapharma (IP) SPRL, Anderlecht
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Fibclot, Fibryga
- Belgium · Fibclot, Fibryga
- Bulgaria · Fibryga, Хемокомплетан P
- Cyprus · Fibryga, Riastap
- Czechia · Fibryga, Haemocomplettan P
- Germany · Fibclot, Fibryga
- Denmark · Fibclot, Fibryga
- Estonia · Fibryga
- Spain · Fibclot, Fibryga
- Finland · Fibclot, Fibryga
- France · Clottafact, Fibryga
- United Kingdom (Northern Ireland) · Fibclot, Fibryga
- Greece · Fibclot, Riastap
- Croatia · Fibryga
- Hungary · Fibclot, Fibryga
- Ireland · Fibryga, Riastap
- Iceland · Fibryga, Riastap
- Italy · Fibriclotte, Fibryga
- Lithuania · Fibryga
- Luxembourg · Fibclot, Fibryga
- Latvia · Fibryga
- Malta · Fibryga, Riastap
- Netherlands · Fibclot, Fibryga
- Norway · Fibclot, Fibryga
- Poland · Fibryga, Riastap
- Portugal · Fibryga, Haemocomplettan
- Romania · Fibryga, Haemocomplettan P
- Slovenia · Fibrema, Prufibry
- Slovakia · Fibryga, Riastap
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0b9f8744-254f-443a-b442-9bab3f7b4c33 GET /v1/drugs/0b9f8744-254f-443a-b442-9bab3f7b4c33?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20150122000014",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20150122000014",
"product_doc_link": "https://docetp.mpa.se/LMF/Fibclot%20powder%20and%20solvent%20for%20solution%20for%20injection%20or%20infusion%20SmPC_09001bee807a2f9b.pdf"
}See everything about human fibrinogen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.